Following treatment with RLN2-secreting CAR-T cells, type IV collagen expression in the tumor was significantly reduced by RLN2-induced MMP-9 and MMP-7 expression, potentially facilitating easier contact between the extravasated CAR-T and cancer cells after traversing the interstitial stroma. The gene discussed is RLN2; the disease is cancer.